I fly. A lot. To educate, to inform, to train scientists and surgeons in the latest advances in cross-linking. Yes, I worry about my carbon footprint. Yes, I miss my family when I’m gone. But it’s important that it’s done, and I explain in this blog post exactly why that’s true.
ELZA takes observerships seriously. When we offer somebody an observership placement, we’ll plan that person’s time carefully to give them the maximum exposure to the clinical, scientific and administrative aspects of the clinic.
Prof. Hafezi in a video interview with EyeWorld at the World Ophthalmology Congress 2018 in Barcelona about the relationship between thyroid hormone and changes in the cornea and in vision.
Prof. Hafezi in a controversy about Cross-Linking with Prof. Damien Gatinel at the Science2Clinix-Kongress in Bangalore.
The ELZA Institute was part of the main lecture program of the 2018 congress of the German ophthalmic surgeons, DOC in Nuremberg.
Prof. Hafezi gives an overview at Science2Clinix 2018 in Bangalore about ELZA’s latest research results on corneal cross-linking research.
The Narayana Nethralaya Hospital in Bangalore, India has become a leader in the field of corneal cell biology in the past 5 years
The ELZA founder Farhad Hafezi has been voted by his peers onto the Powerlist 2018, a list of the 100 top most influential people in ophthalmology.
The ELZA Institute was represented at the 2018 Meeting of the Moroccon Cataract and Refractive Surgeons in Tanger
Fifteen years into the clinical application of corneal cross-linking, we are collecting a growing number of long-term results from patients
